AC Immune (ACIU) EPS (Basic) Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,891.04% |
| Sep 30, 2025 | -385.34% |
| Jun 30, 2025 | 7.90% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | 87.33% |
| Sep 30, 2024 | 129.54% |
| Jun 30, 2024 | -10.07% |
| Mar 31, 2024 | 12.40% |
| Dec 31, 2023 | 75.04% |
| Jun 30, 2023 | 14.50% |
| Mar 31, 2023 | 7.18% |
| Dec 31, 2022 | 5.40% |
| Jun 30, 2022 | 11.76% |
| Mar 31, 2022 | 2.09% |
| Dec 31, 2021 | 6.43% |
| Sep 30, 2021 | 18.83% |
| Jun 30, 2021 | -13.21% |
| Mar 31, 2021 | -141.34% |
| Dec 31, 2020 | 7.98% |
| Sep 30, 2020 | -100.00% |
| Jun 30, 2020 | 100.00% |
| Dec 31, 2019 | -16.04% |
| Dec 31, 2018 | -426.94% |
| Dec 31, 2017 | 186.46% |
| Sep 30, 2017 | -2,144.04% |
| Jun 30, 2017 | -410.47% |
| Dec 31, 2016 | 34.72% |